Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise A Yardley, MD
SCRI Development Innovations, LLC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Integrated Community Oncology Network
Jacksonville, Florida, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Wellstar Cancer Research
Marietta, Georgia, United States
- Graves-Gilbert Clinic
Bowling Green, Kentucky, United States
- Baton Rouge General Medical Center
Baton Rouge, Louisiana, United States
- St. Louis Cancer Care
Chesterfield, Missouri, United States
- Sletten Cancer Institute
Great Falls, Montana, United States
- Chattanooga Oncology & Hematology Associates
Chattanooga, Tennessee, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2006
- Primary completion
- 30 Jun 2010
- Completion
- 30 Jun 2011
- Last update posted
- 18 Nov 2021
- Registered enrollment
- 79
- Registry id
- NCT00405938
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.